P R E S S     R E L E A S E

Dialog Adds Health Sciences Newsletters from NewsRx

CARY, NC, USA, March 22, 2002 -- Dialog, a Thomson business and a leading worldwide provider of online-based information services and integrated information solutions, today announced that it has enhanced its portfolio of health sciences and medical information sources with the addition of 26 full-text newsletters published by NewsRx, a leading health news publisher based near Atlanta, Ga., USA.

The NewsRx newsletters -- focused primarily on pharmaceutical and biotechnology topics as well as diagnostics and medical devices, and organized around therapeutic categories -- are now available for online searching and article retrieval through the information services provided on the Dialog platform of online services (except DialogSelect(sm)).

In addition to newly published editions of the weekly newsletters, updated in the Dialog database concurrently with print publication, an archive of past issues starting from 1995 is also available for online searching and article retrieval.

NewsRx titles now available are: AIDS Weekly, Angiogenesis Weekly, Biotech Week, Bio-Terrorism Info, Blood Weekly, Cancer Weekly, Diabetes Week, Drug Week, Gene Therapy Weekly, Genomics & Genetics Weekly, Health & Medicine Week, Genomics & Genetics Weekly, Hepatitis Weekly, Immunotherapy Weekly, Medical Letter on the CDC & FDA, Managed Healthcare Info, Medical Devices & Surgical Technology Week, Obesity Fitness & Wellness Week, Pain & Central Nervous System Week, Proteomics Weekly, Stem Cell Week, TB & Outbreaks Week, Vaccine Weekly, Vector & Zoonosis Week, Virus Weekly and Women's Health Weekly.

"We're delighted to add the NewsRx publications to our services," said David Brown, Dialog senior vice president, content development. "NewsRx is rightly recognized as one of the world's great publishers of health sciences information. Its editorial approach of offering in-depth yet accessible coverage of health, medicine and related subjects will be a boost to our users in the pharmaceutical, biotech, healthcare and research communities around the world, as well as to the healthcare providers we serve."

Dialog is one of the world's premier providers of research on a wide range of health, pharmaceutical and biotechnology topics. Its services provide access to thousands of publications, research documents and other information sources in the health and biotechnology arenas, in addition to extensive collection of company, industry, intellectual property and regulatory information sources.

The NewsRx newsletters are available on the Dialog services as File 135. The publications have been available on Dialog's DataStar™ service, since September 2001 (file label: RXNS).

• View the File 135 Bluesheet.
• View the RXNS Datasheet.

- Ends -

About Dialog
Founded in 1972 by Dr. Roger K. Summit, a pioneer in developing the technology behind electronic information retrieval, Dialog is the world leader in providing online-based information services to organizations seeking competitive advantages in such fields as business, science, engineering, finance and law.

Today, Dialog's three online platforms -- Dialog®, Profound® and DataStar™ -- offer users the ability to precisely retrieve data from more than 1.2 billion unique records, accessible via the Internet or through delivery to enterprise intranets. The content available ranges from articles and reports published in thousands of publications to in-depth repositories of patents, trademarks and other intellectual property data.

Corporate librarians, knowledge managers and other information professionals at more than 25,000 business, professional and government organizations in more than 100 countries prize Dialog services for their breadth and depth of content, precision searching and speed.

Headquartered in Cary, N.C., USA, with direct operations in 32 countries throughout North American, Latin America, Europe, the Middle East, South Africa and the Asia Pacific, Dialog is a business of The Thomson Corporation. For more information about Dialog, please visit www.dialog.com. Or, please call (U.S./Canada) 800-3-DIALOG or (U.S.) 919-462-8600. Dialog's London office may be reached at (44) (0) 207-940-6900.

About The Thomson Corporation
The Thomson Corporation (www.thomson.com), with 2001 revenues of $7.2 billion, is a leading provider of integrated information solutions to business and professional markets worldwide. The Corporation's common shares are listed on the Toronto (TSE: TOC) and London stock exchanges.

-30-

All designated trademarks used herein are the property of The Dialog Corporation or its subsidiaries. Registered marks are registered by The Dialog Corporation or its subsidiaries with the U.S. Patent and Trademark Office. All other marks are trademarks or registered trademarks of their respective owners.

About NewsRx
NewsRx, the leading provider of life science databases and daily and weekly health news, provides over one million pages of health information each year to pharmaceutical companies, medical researchers, public health authorities, educators and managed-care professionals. Both in numbers of articles and report titles, it is the world's largest provider of health news and information to the pharmaceutical and healthcare industries. NewsRx provides information and data products using its proprietary Journalist Assisted Technology (JAT) and Component Aggregation Technology (CAT). Its news database library at NewsRx.com contains over 130,000 health and science related articles. At NewsRx.net, 20,000 database reports are updated monthly on almost any niche health or science subject. The company's headquarters is in a metro Atlanta city, Sugar Hill, Georgia, USA.

top